Nr4a2 blocks oAβ-mediated synaptic plasticity dysfunction and ameliorates spatial memory deficits in the APP _Sw,Ind...

Area of Science:

• Neuroscience
• Molecular Biology
• Pathology

Background:

• Alzheimer's disease (AD) involves impaired neuronal communication, particularly in the hippocampus, affecting learning and memory.
• The amyloid hypothesis posits that amyloid-beta oligomers (oAβ) cause synaptic dysfunction via AMPA receptor internalization.
• Nr4a2, an orphan nuclear receptor, regulates hippocampal synaptic plasticity, BDNF, and AMPA receptors.

Approach:

• Investigated the effect of oAβ on activity-dependent Nr4a2 activation in hippocampal neurons.
• Analyzed Nr4a2 protein levels in postmortem hippocampal tissues from early AD stages.
• Evaluated the therapeutic potential of Nr4a2 activation using pharmacological methods and genetic overexpression in AD mouse models.

Key Points:

• oAβ inhibits activity-dependent Nr4a2 activation in hippocampal neurons, linking oAβ to Nr4a2 downregulation.
• Reduced Nr4a2 protein levels were observed in early-stage AD hippocampal tissues.
• Pharmacological Nr4a2 activation prevented oAβ-induced synaptic depression.
• Nr4a2 overexpression in AD mouse models improved spatial learning and memory.

Conclusions:

• oAβ may cause early cognitive impairment in AD by inhibiting Nr4a2 activation, leading to synaptic dysfunction.
• Nr4a2 activation represents a potential therapeutic target for mitigating oAβ-induced synaptic and cognitive deficits in early AD.